99 related articles for article (PubMed ID: 2205037)
1. [Fluconazole. A new antimycotic for systemic use].
Hartzen SH; Frimodt-Møller N; Korner B
Ugeskr Laeger; 1990 Aug; 152(32):2321-4. PubMed ID: 2205037
[No Abstract] [Full Text] [Related]
2. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
3. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
Shahid Z; Sobel JD
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
[TBL] [Abstract][Full Text] [Related]
4. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
[TBL] [Abstract][Full Text] [Related]
6. Fluconazole resistant non-albicans vaginal yeast in HIV seronegative women with vaginal discharge in Pune, India.
Kairon R; Godbole S; Kulkarni S; Ghate M; Sane S; Mehendale S; Risbud A; Shrotri A; Bharucha K
Int J Infect Dis; 2004 Jul; 8(4):251-2. PubMed ID: 15234330
[No Abstract] [Full Text] [Related]
7. Fluconazole for the treatment of candidiasis: 15 years experience.
Cha R; Sobel JD
Expert Rev Anti Infect Ther; 2004 Jun; 2(3):357-66. PubMed ID: 15482201
[TBL] [Abstract][Full Text] [Related]
8. Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy.
Ventolini G; Baggish MS; Walsh PM
J Reprod Med; 2006 Jun; 51(6):475-8. PubMed ID: 16846086
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
[TBL] [Abstract][Full Text] [Related]
10. Oral fluconazole for vaginal candidiasis.
Desai PC; Johnson BA
Am Fam Physician; 1996 Sep; 54(4):1337-40, 1345-6. PubMed ID: 8816577
[TBL] [Abstract][Full Text] [Related]
11. Anidulafungin treatment for fluconazole-resistant
Akdağ D; Pullukçu H; Yamazhan T; Metin DY; Sipahi OR; Ener B; Işıkgöz Taşbakan M
J Obstet Gynaecol; 2021 May; 41(4):665-666. PubMed ID: 32312119
[No Abstract] [Full Text] [Related]
12. [Fluconazole for recurrent vulvovaginal candidiasis].
Tietz HJ
Med Monatsschr Pharm; 2009 Jun; 32(6):227. PubMed ID: 19554833
[No Abstract] [Full Text] [Related]
13. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
[TBL] [Abstract][Full Text] [Related]
14. The effects of miconazole on the ultrastructure of Candida albicans.
De Nollin S; Borgers M; Van Belle H
Proc R Soc Med; 1977; 70 Suppl 4(Suppl 4):19-23. PubMed ID: 122689
[No Abstract] [Full Text] [Related]
15. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
Cernicka J; Subik J
Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
[TBL] [Abstract][Full Text] [Related]
17. [Study on classification and treatment of vulvovaginal candidiasis].
Fan SR; Liu XP; Li JW; Xu AP; Liu M
Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):532-5. PubMed ID: 16202291
[TBL] [Abstract][Full Text] [Related]
18. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole.
Sobel JD; Kapernick PS; Zervos M; Reed BD; Hooton T; Soper D; Nyirjesy P; Heine MW; Willems J; Panzer H; Wittes H
Am J Obstet Gynecol; 2001 Aug; 185(2):363-9. PubMed ID: 11518893
[TBL] [Abstract][Full Text] [Related]
19. Treatment of candidal vaginitis with miconazole, a new broad-spectrum antimycotic. Changes in microbiology, vaginal pH and cytology.
Peeters F; Snauwaert R; Segers J; Van Cutsem J; Amery W
Arzneimittelforschung; 1973 Aug; 23(8):1107-11. PubMed ID: 4588098
[No Abstract] [Full Text] [Related]
20. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).
Vazquez JA; Sobel JD; Peng G; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 1999 May; 28(5):1025-31. PubMed ID: 10452629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
